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Antibiotic Spacers in Shoulder Arthroplasty:
Comparison of Stemmed and Stemless Implants
Eric M Padegimas, MD, Alexia Narzikul, BA, Cassandra Lawrence, BS, Benjamin A Hendy, MD,
Joseph A Abboud, MD*, Matthew L Ramsey, MD*, Gerald R Williams, MD*, Surena Namdari, MD*
Department of Orthopaedic Surgery, Thomas Jefferson University Hospital, Philadelphia, PA,
*Department of Orthopaedic Surgery, The Rothman Institute, Thomas Jefferson University Hospital, Philadelphia, PA, USA

Background: Antibiotic spacers in shoulder periprosthetic joint infection deliver antibiotics locally and provide temporary stability.
The purpose of this study was to evaluate differences between stemmed and stemless spacers.
Methods: All spacers placed from 2011 to 2013 were identified. Stemless spacers were made by creating a spherical ball of cement placed in the joint space. Stemmed spacers had some portion in the humeral canal. Operative time, complications, reimplantation, reinfection, and range of motion were analyzed.
Results: There were 37 spacers placed: 22 were stemless and 15 were stemmed. The stemless spacer population was older (70.9 ±
7.8 years vs. 62.8 ± 8.4 years, p = 0.006). The groups had a similar percentage of each gender (stemless group, 45% male vs. stemmed
group, 40% male; p = 0.742), body mass index (stemless group, 29.1 ± 6.4 kg/m2 vs. stemmed group, 31.5 ± 8.3 kg/m2; p = 0.354) and
Charlson Comorbidity Index (stemless group, 4.2 ± 1.2 vs. stemmed group, 4.2 ± 1.7; p = 0.958). Operative time was similar (stemless
group, 127.5 ± 37.1 minutes vs. stemmed group, 130.5 ± 39.4 minutes). Two stemless group patients had self-resolving radial nerve
palsies. Within the stemless group, 15 of 22 (68.2%) underwent reimplantation with 14 of 15 having forward elevation of 109º ± 23º.
Within the stemmed group, 12 of 15 (80.0%, p = 0.427) underwent reimplantation with 8 of 12 having forward elevation of 94º ± 43º
(range, 30º to 150º; p = 0.300). Two stemmed group patients had axillary nerve palsies, one of which self-resolved but the other did not.
One patient sustained dislocation of reverse shoulder arthroplasty after reimplantation. One stemless group patient required an open
reduction and glenosphere exchange of dislocated reverse shoulder arthroplasty at 6 weeks after reimplantation.
Conclusions: Stemmed and stemless spacers had similar clinical outcomes. When analyzing all antibiotic spacers, over 70%
were converted to revision arthroplasties. The results of this study do not suggest superiority of either stemmed or stemless antibiotic spacers.
Keywords: Shoulder, Arthroplasty, Replacement, Prosthesis-related infections, Arthritis infectious

Periprosthetic joint infection (PJI) in shoulder arthroplasty
remains a diagnostic and management conundrum. The
reported infection rate after primary shoulder arthroplasty
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is just under 1%1) and it is approximately 5% after primary
reverse shoulder arthroplasty.2) Treatment options include
antibiotic treatment, irrigation and debridement, singlestage revision, two-stage revision, resection arthroplasty,
and arthrodesis.3-9) While there is no definitive standard
of care for the treatment of infected shoulder arthroplasty,
two-stage revision is often utilized in a similar fashion to
the common practice in hip and knee PJI.10-14) Placement
of an antibiotic spacer may be a bridge to a definitive arthroplasty with a two-stage revision or a definitive management option for PJI. Stine et al.15) showed that the use
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The study was approved by the Institutional Review Board
of Thomas Jefferson University Hospital (IRB No. 45 CFR
46.110; #16D.594) and performed in accordance with the

principles of the Declaration of Helsinki. Informed consent was waived as this was purely retrospective review
without intervention. After approval from the Institutional
Review Board, we performed a retrospective analysis of
our institutional shoulder arthroplasty database between
January 1, 2011 and December 31, 2013. This database
identified all primary and revision shoulder arthroplasty
cases defined by the International Classification of Diseases, ninth revision, clinical modification (ICD-9-CM)
codes. The codes utilized were 79.31 (open reduction of
fracture of humerus), 80.01 (arthrotomy for removal of
a prosthesis without replacement), 81.80 (total shoulder
arthroplasty), 81.81 (shoulder hemiarthroplasty), 81.82
(repair of recurrent dislocation of shoulder), 81.83 (other
repair of shoulder, arthroplasty), 81.88 (reverse total shoulder arthroplasty), and 81.97 (revision joint replacement
upper extremity). Direct chart review was then performed
to identify the subpopulation of patients that underwent
placement of an antibiotic spacer. Operative notes and
postoperative radiographs were utilized to determine if the
antibiotic spacer was stemmed (Fig. 1) or stemless (Fig. 2).
Prefabricated implants were not utilized. All spacers were
created with tobramycin and vancomycin. All stemless
spacers were made by creating a spherical ball of cement
that was placed in the joint space. Any antibiotic spacer
that had any cement that entered into the humeral canal
was considered a stemmed implant. All stemmed spacers were created by fashioning cement into the shape of a
stemmed humeral implant, with or without placement of a
central, pre-bent wire. Complete medical records were reviewed to determine the total operative time from skin incision to skin closure in each case as well as complications.

Fig. 1. Anteroposterior radiograph of a stemmed implant.

Fig. 2. Anteroposterior radiograph of a stemless implant.

of an articulating spacer was a suitable definitive treatment
option in some patients; however, others experienced persistent pain and limited function that led to reimplantation.
The topic of antibiotic spacer types has been wellstudied in two-stage revision for hip and knee PJI. Recent
analyses have suggested that dynamic spacers have improved functional outcomes and better soft tissue preservation when compared to static spacers.16-18) Furthermore,
the use of dynamic spacers in two stage-revision knee
arthroplasty allows for increased range of motion throughout the treatment with the spacer leading to reduced bone
loss and less muscle atrophy without any evidence of
significant wear damage.19) In shoulder PJI, there are two
main categories of antibiotic spacers utilized in two-stage
revisions: stemmed and stemless. The clinical differences
between these two implant choices have not yet been studied. For the purpose of this study, any antibiotic spacer
that had any cement that entered into the humeral canal
was considered a stemmed implant while any implant that
was formed by simply creating a sphere of cement that was
placed into the joint cavity after debridement was considered stemless. The purpose of this study was to evaluate all
patients who underwent antibiotic spacer placement and
evaluate differences in outcomes between the stemmed
and stemless implants.

METHODS

491
Padegimas et al. Stemmed versus Stemless Shoulder Spacers
Clinics in Orthopedic Surgery • Vol. 9, No. 4, 2017 • www.ecios.org

Operative cultures were reviewed for identification of infecting organism(s). Postoperative clinic notes at 2, 6, and
12 weeks as well as the final clinic note in our electronic
medical records were reviewed to determine whether or
not patients underwent reimplantation, the timing of reimplantation, and final range of motion after reimplantation. At a minimum of 2 years of clinical follow-up, recurrence of infection and any future reoperations following
reimplantation were determined.
Descriptive statistics were utilized to compare the
two antibiotic spacer subpopulations. Differences in categorical variables were evaluated by comparison of zscores of proportions while continuous variables were
evaluated by Student paired t-tests. Preoperative variables
compared between two spacer subpopulations were age,
gender, body mass index (BMI), and age-adjusted Charlson Comorbidity Index (CCI).20,21) The operative times of
antibiotic spacer placement were then compared between
the two groups. The rates of reimplantation (second stage
of the two-stage revision) were analyzed. Finally, in patients who underwent reimplantation, range of motion in
forward elevation was measured at the latest postoperative
visit (minimum 6 months). This range of motion data was
directly collected by the surgeon. All statistics were calculated with Microsoft Excel 2013 (Redmond, WA, USA).

RESULTS
Retrospective review of our institutional shoulder arthroplasty database identified 37 patients who underwent
antibiotic spacer placement over the study period. There
were 22 stemless implants (59.5%) placed and 15 stemmed
implants (40.5%). The stemless group had an average age
of 70.9 ± 7.8 years (range, 54.6 to 84.7 years), was 45.5%
male, had an average BMI of 29.1 ± 6.4 kg/m2 (range, 19.5
to 48.0 kg/m2), and had an average age-adjusted CCI of 4.2
± 1.2 (range, 2 to 6). There were two intraoperative complications in the stemless group; both were nerve injuries
with electromyography-proven radial nerve palsies that
self-resolved within 6 months of surgery. The culture data
from the stemless group revealed that 12 of 22 (54.5%) had
positive cultures: four isolated Propionibacterium acnes
(33%), three coagulase-negative Staphylococcus species
(CNS, 25%), 2 methicillin-sensitive Staphylococcus aureus
(MSSA, 16.7%), one Enterococcus faecalis (8.3%), one
Escherichia coli (8.3%), and one with both MSSA and P.
acnes (8.3%). In comparison, the stemmed group had an
average age of 62.8 ± 8.4 years (range, 48.0 to 81.9 years; p
= 0.006), was 40% male (p = 0.742), had an average BMI of
31.5 ± 8.3 kg/m2 (range, 21.5 to 47.6 kg/m2; p = 0.354), and
an average age-adjusted CCI of 4.2 ± 1.7 (range, 2 to 8; p
= 0.958). Operative time for the stemless group was 127.5
± 37.1 minutes (range, 62 to 200 minutes) compared to
130.5 ± 39.4 minutes (range, 74 to 188 minutes; p = 0.820)

Table 1. Comparison of Stemmed and Stemless Groups
Stemless (n = 22)

Stemmed (n = 15)

p -value

Age (yr)*

70.9 ± 7.8 (54.6–84.7)

62.8 ± 8.4 (48.0–81.9)

0.006

Body mass index (kg/m2)*

29.1 ± 6.4 (19.5–48.0)

31.5 ± 8.3 (21.5–47.6)

0.354

Category

Charlson Comorbidity Index*

4.2 ± 1.2 (2–6)

4.2 ± 1.7 (2–8)

†

0.958
0.742

Sex (%)
Male

45.5

40.0

Female

54.5

60.0

127.5 ± 37.1

130.5 ± 39.4

0.820

Reimplantation

143 ± 42

154 ± 70

0.653

Reimplantation (%)†

68.2

80.0

0.427

109 ± 23 (70–150)

94 ± 43 (30–150)

0.300

Operative time (min)*
Index spacer

Forward elevation (º)*

Values are presented as mean ± standard deviation (range) or mean ± standard deviation.
*Comparison of continuous variables calculated by two sample t -test with equal variance. †Comparison of proportional variables calculated by two sample z-test
for comparing proportions.
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in the stemmed group. There were no intraoperative complications in the stemmed group. The culture data from
the stemmed group was available for 14 of 15 patients and
revealed that 7 of 14 (50.0%) had positive cultures: four
isolated P. acnes (57.1%) and three MSSA (42.8%) (Table 1).
In the entire antibiotic spacer population, 27 of 37
patients (73.0%) underwent revision to definitive arthroplasty. Within the stemless group, 15 of 22 of patients
(68.2%) went on to 18 future surgeries (two spacer exchanges, 15 reverse shoulder arthroplasties, and one open
reduction of a dislocated reverse shoulder arthroplasty

with glenosphere exchange) at an average of 6.8 ± 8.5
months (range, 0.8 to 34.0 months) after the index spacer
placement (Table 2). In those stemless patients who were
converted to a revision arthroplasty, 14 of 15 (93.3%) had
final range of motion data at an average follow-up of 23.2
± 11.9 months (range, 6.0 to 44.5 months). These patients
had an average forward elevation of 109° ± 23° (range, 70°
to 150°). The operative time for definitive reimplantation
after stemless spacer placement was 143 ± 42 minutes
(range, 89 to 236 minutes). There were no intraoperative complications in reimplantation within the stemless

Table 2. Surgical Variables for All Patients That Underwent Stemless Spacer Placement
Diagnosis at time of spacer placement

Months to
reimplantation

Surgery at
reimplantation

Reoperation after
reimplantation

Sex

Age (yr)

Female

84.7

Chronically dislocating TSA for OA from OSH

NA

NA

NA

Male

69.1

Infected RTSA for CTA from OSH

36.1

RTSA

No

Female

59.6

TSA for PTA with deep infection

18.4

2 Spacer revisions
and RTSA

No

Female

76.2

Infected RTSA for CTA from OSH

NA

NA

NA

Male

73.4

Infected primary TSA from OSH

NA

NA

NA

Male

73.5

Infected primary TSA from OSH

NA

NA

NA

Female

82.0

Infected HA for CTA from OSH

51.7

RTSA

No

Male

54.6

Infected TSA with multiple I&Ds from OSH

40.8

RTSA

No

Male

62.6

Chronically dislocating RTSA for CTA from OSH

28.7

RTSA

No

Female

68.8

Infected TSA for OA

54.1

RTSA

No

Female

66.9

Infected HA for proximal humerus fracture from OSH

63.4

RTSA

Open reduction and
glenosphere
exchange at 6 weeks

Male

72.7

Primary septic arthritis in setting of CTA

37.4

RTSA

No

Female

75.1

Infected TSA with dislocated glenoid from OSH

58.5

RTSA

No

Male

61.0

TSA with significant loosening and metallosis

49.2

RTSA

No

Female

63.6

Chronically dislocating RTSA for CTA from OSH

32.3

RTSA

No

Female

81.9

Nonunion of RTSA periprosthetic fracture

37.0

RTSA

No

Female

63.9

Infected RTSA for fracture from OSH

NA

NA

NA

Male

71.5

TSA glenoid and humeral loosening

41.4

RTSA

No

Female

71.1

Chronically infected HA from OSH

NA

NA

NA

Female

71.2

Infected TSA for OA

40.8

RTSA

No

Male

77.4

Infected RTSA for CTA from OSH

59.9

RTSA

No

Male

78.3

Chronically infected TSA from OSH

NA

NA

NA

TSA: total shoulder arthroplasty, OA: osteoarthritis, OSH: outside hospital, NA: not applicable, RTSA: reverse total shoulder arthroplasty, CTA: cuff tear
arthropathy, PTA: posttraumatic arthritis, HA: hemiarthroplasty, I&D: irrigation and debridement.
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group. Intraoperative cultures were drawn for 14 of 15
reimplantations in the stemless group with 3 of 15 (20.0%)
having at least one positive culture: one had negative cultures, but P. acnes were found on gram stain (this patient
had negative cultures at the index spacer placement), one
grew P. acnes (this patient had P. acnes at the index spacer
placement), and one grew CNS (this patient had negative cultures at the index spacer placement). The first of
these patients was treated as contaminant, while the other
two were treated with oral antibiotics for 6 weeks. None
of these three patients had clinical evidence of infection
postoperatively. One stemless patient underwent reoperation for a dislocated reverse shoulder arthroplasty at 6
weeks after reimplantation. This patient required an open
reduction with glenosphere exchange. With the exception
of one reoperation, no patient required future reoperation
at an average follow-up of 3.6 ± 1.0 years (range, 1.5 to 5.2
years).
Within the stemmed group, 14 of 15 (93.3%) went
on to 15 future surgeries (two spacer revisions, one resection arthroplasty, one long-stemmed hemiarthroplasty,
four total shoulder arthroplasties, and seven reverse shoulder arthroplasties) with 12 of 15 (80.0%, p = 0.427) under-

going definitive reimplantation at an average of 2.4 ± 0.7
months (range, 0.7 to 4.4 months) after the index spacer
placement (Table 3). In those stemmed patients who were
converted to a revision arthroplasty, 8 of 12 (66.7%) had
final range of motion data at an average follow-up of 18.8
± 8.5 months (range, 6.4 to 35.8 months). These patients
had an average forward elevation of 94° ± 43° (range, 30°
to 150°; p = 0.300). The operative time for definitive reimplantation after stemmed spacer placement was 154 ± 70.1
minutes (range, 57 to 304 minutes; p = 0.653). There were
three complications during reimplantation in the stemmed
spacer group. One patient was found to have a dislocated
reverse shoulder arthroplasty in the recovery room on
postoperative radiographs at which point the patient was
brought back to the operating room for closed reduction. Two patients were found to have atrophy and loss of
contractility of the anterior and middle deltoid. One had
a confirmed diagnosis of axillary nerve palsy on electromyography that self-resolved within 6 months, while the
other refused electromyography and had an incomplete
return of function. Intraoperative cultures were recorded
for 11 of 12 reimplantations in the stemmed group with 3
of 11 (27.3%) having at least one positive culture. In these

Table 3. Surgical Variables for All Patients That Underwent Stemmed Spacer Placement
Diagnosis at time of spacer placement

Months to
reimplantation

Surgery at
reimplantation

Reoperation after
reimplantation

Sex

Age (yr)

Female

70.1

Infected HA for proximal humerus fracture from OSH

NA

NA

NA

Male

48.0

Infected HA for RA from OSH

3.5

Long stem HA

No

Male

57.6

Infected HA for CTA from OSH

1.9

RTSA

No

Female

61.7

Loosening of HA for proximal humerus fracture from OSH

1.2

RTSA

No

Female

62.9

Infected HA for proximal humerus fracture from OSH

3.5

RTSA

No

Male

60.3

Infected TSA and rotator cuff tear from OSH

3.7

RTSA

No

Female

60.0

Septic arthritis after arthroscopic debridement from OSH

1.2

RTSA

No

Male

57.7

Primary septic arthritis from injection with I&D at OSH

0.9

RTSA

No

Female

70.8

Chronic osteomyelitis after open acromioplasty at OSH

0.7

RTSA

No

Female

64.1

Infected HA for proximal humerus fracture from OSH

NA

NA

NA

Female

65.7

Glenoid and humeral loosening of TSA from OSH–Nickel allergy

3.6

Nickel free TSA

No

Female

51.7

Glenoid and humeral loosening of TSA from OSH–Nickel allergy

2.3

Nickel free TSA

No

Female

70.8

Painful HA with glenoid wear from OSH–elevated ESR/CRP

1.4

TSA

No

Male

59.4

Osteomyelitis after rotator cuff repair from OSH

4.4

TSA

No

Male

81.9

TSA with glenoid erosion from OSH

NA

NA

NA

HA: hemiarthroplasty, OSH: outside hospital, NA: not applicable, RA: rheumatoid arthritis, CTA: cuff tear arthropathy, RTSA: reverse total shoulder arthroplasty,
TSA: total shoulder arthroplasty, I&D: irrigation and debridement, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein.
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three patients, one grew E. coli (one colony in broth only;
grew P. acnes at the index spacer placement) and two grew
an unspecified bacillus species (both one colony in broth
only; both were negative at the index spacer placement).
These were all treated as contaminant without clinical
evidence of infection postoperatively. Following reimplantation from a stemmed spacer, there were no further
reoperations performed at an average follow-up of 4.0 ± 0.8
years (range, 2.4 to 5.2 years). There were no clinical reinfections in either the stemless or stemmed population.

DISCUSSION
The role of two-stage revision in management of shoulder
PJI has been well-described.3-9) Spacer placement is a viable option either as a bridge to reimplantation or as a definitive treatment modality. In our study, over three quarters of patients went on to have revision arthroplasty while
the rest retained the spacer as a definitive implant. In both
groups, the infection was adequately treated as there were
no clinical signs of recurrent infections. Additionally, there
was only one reoperation after reimplantation (glenosphere
exchange for a reverse shoulder arthroplasty at 6 weeks
after reimplantation), and there was no statistical difference between the stemmed and stemless spacers in terms
of eventual reimplantation.
In hip and knee PJI, recent analyses found improved
functional outcomes and better soft tissue preservation of
dynamic spacers when compared to static spacers.16-18) Prior to this study, there has not been an analysis on the ideal
antibiotic spacer design in shoulder PJI. One advantage of
stemless spacers that we expected was reduced operative
time since the implant can be made from the beginning
of the case and is easily inserted in the joint. However, we
found similar operative times for implantation of both designs. It is likely that the operative time of complex shoulder PJI cases is driven by a number of technical variables,
such as ease of stem excision, and that the effect of spacer
type is negligible. Additionally, operative time of reimplantation was similar between the groups. This suggests
that both implant types equally maintained the joint space
and both are equally easy to remove upon revision surgery.
Finally, the similar range of motion data after definitive
reimplantation suggests that the choice of a stemmed or
stemless implant does not have a major impact on the final
functional outcome. While neither group returned to full
range of motion, they did achieve similar forward elevation to that previously described for revision of hemiarthroplasty to reverse total shoulder arthroplasty.22,23)
There were five total complications in the entire

study group, two with index stemless spacer placement
and three with reimplantation after stemmed implant
placement. These complications included four neurologic
injuries and one reverse shoulder arthroplasty dislocation.
There were 70 total surgeries performed in our entire population which gives a neurologic injury rate of 5.7%, three
of which completely resolved and one of which incompletely resolved. The literature reports a rate of neurologic
injury of 1% to 4.3% in anatomic total shoulder arthroplasty24,25) and from 1.7% to 11.6% in reverse shoulder arthroplasty26-28) with revision surgery being a risk factor for
neurologic injury.29) The rate of neurologic injury in our
patient population is within the range we expected given
the complex nature of these cases. Three of these neurologic deficits fully resolved while one partially resolved,
consistent with previous reports of these injuries being
stretch neuropraxias rather than transection injuries.25,27)
Regarding bacterial cultures at the time of reimplantation,
all patients that had one or less positive culture at the time
of reimplantation were treated as a contaminant while
those with two or more positive cultures were treated as
true positive cultures per the protocol described by Frangiamore et al.30) The two patients that met this criteria of
culture positivity at the time of reimplantation were given
6 weeks of postoperative antibiotics. There were no reinfections after reimplantation in this study.
The findings of this study must be considered in the
context of the limitations. First, the majority of our patients went on to have revision arthroplasty, which did not
allow us to further study the differences between stemmed
and stemless spacers as a final treatment option. Also, we
did not have sufficient patient reported outcomes to fully
analyze functional differences. While similar outcomes in
forward elevation may provide a general idea of functional
level, the availability of other outcomes, such as patientspecific functional results, would have been more substantial. Additionally, this is a purely retrospective study and
therefore we can only determine associative relationships
rather than speculate on causality. These were also very
complex patients from both medical and technical perspectives. Therefore, retrospective analysis of the details
of their clinical course is difficult. In order to mitigate this
weakness, all of the patient charts were reviewed directly
in their entirety instead of simply relying on the institutional database. Finally, because this was a retrospective study, the patient numbers were set without power
analysis. Therefore, the nonsignificant trend of a higher
reimplantation rate in patients with stemmed spacers may
simply be a result of an underpowered study rather than
truly nonsignificant.
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This study offers the first comparison between patients with stemmed antibiotic spacers and stemless antibiotic spacers in shoulder arthroplasty. The patient populations that underwent stemmed and stemless antibiotic
spacer placement were statistically similar in complication
rate, final reimplantation rate, operative time, and final
active forward elevation. When analyzing all antibiotic
spacers, over 70% were converted to revision arthroplasties, after which there was one reoperation and no clinical

reinfections. The results of this study do not suggest superiority of either stemmed or stemless antibiotic spacers.
Future prospective analysis may determine differences in
outcomes not observed in this study.
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